Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies

SIMPLE SUMMARY: Epidermal growth factor receptor (EGFR) mutations occur in a significant number of lung cancer patients. Treatment outcomes in this subset of patients has greatly improved over the last decade after the introduction of EGFR tyrosine kinase inhibitors (TKIs), which demonstrated high e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Khaddour, Karam, Jonna, Sushma, Deneka, Alexander, Patel, Jyoti D., Abazeed, Mohamed E., Golemis, Erica, Borghaei, Hossein, Boumber, Yanis
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267708/
https://ncbi.nlm.nih.gov/pubmed/34202748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados